The dopaminergic basis of cognitive and motor performance in Alzheimer's disease

by Suzanne Reeves, Mitul Mehta, Robert Howard, Paul Grasby, Richard Brown
Published 2010-02-01

Misidentification Subtype of Alzheimer's Disease Psychosis Predicts a Faster Cognitive Decline

by Fabrizia D'Antonio, Suzanne Reeves, Yucheng Sheng, Emma McLachlan, Carlo deLena, Robert Howard, Julie Bertrand
Published 2019-05-01

Region-specific blood–brain barrier transporter changes leads to increased sensitivity to amisulpride in Alzheimer’s disease

by Gayathri Nair Sekhar, Alice L. Fleckney, Sevda Tomova Boyanova, Huzefa Rupawala, Rachel Lo, Hao Wang, Doaa B. Farag, Khondaker Miraz Rahman, Martin Broadstock, Suzanne Reeves, Sarah Ann Thomas
Published 2019-12-01

Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT

by Robert Howard, Olga Zubko, Richard Gray, Rosie Bradley, Emma Harper, Linda Kelly, Lynn Pank, John O’Brien, Chris Fox, Naji Tabet, Gill Livingston, Peter Bentham, Rupert McShane, Alistair Burns, Craig Ritchie, Suzanne Reeves, Simon Lovestone, Clive Ballard, Wendy Noble, Gordon Wilcock, Ramin Nilforooshan
Published 2020-04-01

Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT

by Robert Howard, Elizabeth Cort, Rosie Bradley, Emma Harper, Linda Kelly, Peter Bentham, Craig Ritchie, Suzanne Reeves, Waleed Fawzi, Gill Livingston, Andrew Sommerlad, Sabu Oomman, Ejaz Nazir, Ramin Nilforooshan, Robert Barber, Chris Fox, Ajay Macharouthu, Pranathi Ramachandra, Vivek Pattan, John Sykes, Valerie Curran, Cornelius Katona, Tom Dening, Martin Knapp, Renee Romeo, Richard Gray
Published 2018-11-01